| Product ID | CAS No. | Product Names | Chemical Structure | Formula(M.F.) | Purity |
| TBW02975 | 52809-07-1 | Quisqualic acid |  |
C5H7N3O5 | >=98%(HPLC) |
| TBW02974 | 1145671-36-8 | 4-Chloroquinazoline-6，7-diol |  |
C8H5ClN2O2 | >=98%(HPLC) |
| TBW02973 | 105679-22-9 | 7-Bromo-3，4-dihydro-2H-1，4-benzoxazine |  |
C8H8BrNO | >=98%(HPLC) |
| TBW02972 | 129648-07-3 | Bisdimethylphospholanoethane |  |
C14H28P2 | >=98%(HPLC) |
| TBW02971 | 915403-19-9 | Benzoic acid，3-amino-5-methoxy-，ethyl ester |  |
C10H13NO3 | >=98%(HPLC) |
| TBW02970 | 301666-04-6 | Benzoic acid，5-amino-2-methoxy-，ethyl ester |  |
C10H13NO3 | >=98%(HPLC) |
| TBW02969 | 128064-55-1 | Benzoic acid，3-amino-5-methyl-，ethyl ester |  |
C10H13NO2 | >=98%(HPLC) |
| TBW02961 | 2380-86-1 | 6-Hydroxyindole |  |
C8H7NO | >=98%(HPLC) |
| TBW02959 | 55265-25-3 | 2-(2-chloroethoxy)ethan-1-amine hydrochloride |  |
C4H11Cl2NO | >=98%(HPLC) |
| TBW02954 | 170908-81-3 | DOTA-NHS-ester | .GIF) |
C20H31N5O10 | >=98%(HPLC) |
| TBW02951 | 1427191-48-7 | 1427191-48-7 |  |
C18H31NO12S | >=98%(HPLC) |
| TBW02947 | 100477-88-1 | Entadamide A |  |
C6H11NO2S | >=98%(HPLC) |
| TBW02946 | 117693-41-1 | DesosaMinylazithroMycin |  |
C30H58N2O9 | >=98%(HPLC) |
| TBW02944 | 301-02-0 | Oleamide |  |
C18H35NO | >=98%(HPLC) |
| TBW02943 | 146616-66-2 | BODIPY FL NHS Ester |  |
C18H18BF2N3O4 | >=98%(HPLC) |
| TBW02942 | 165599-63-3 | 3-Bodipy-propanoic Acid |  |
C14H15BF2N2O2 | >=98%(HPLC) |
| TBW02941 | 341031-54-7 | Sunitinib Malate |  |
C26H33FN4O7 | >=98%(HPLC) |
| TBW02940 | 918504-65-1 | Vemurafenib |  |
C23H18ClF2N3O3S | >=98%(HPLC) |
| TBW02939 | 871700-17-3 | Trametinib |  |
C26H23FIN5O4 | >=98%(HPLC) |
| TBW02938 | 475207-59-1 | Sorafenib tosylate |  |
C28H24ClF3N4O6S | >=98%(HPLC) |
| TBW02937 | 835621-07-3 | Regorafenib (Hydrochloride) |  |
C21H16Cl2F4N4O3 | >=98%(HPLC) |
| TBW02936 | 635702-64-6 | Pazopanib hydrochloride |  |
C21H23N7O2S.ClH | >=98%(HPLC) |
| TBW02935 | 936563-96-1 | Ibrutinib |  |
C25H24N6O2 | >=98%(HPLC) |
| TBW02933 | 1269440-17-6 | Encorafenib |  |
C22H27ClFN7O4S | >=98%(HPLC) |
| TBW02934 | 1195768-06-9 | Dabrafenib Mesylate |  |
C24H24F3N5O5S3 | >=98%(HPLC) |
| TBW02932 | 179324-69-7 | Bortezomib |  |
C19H25BN4O4 | >=98%(HPLC) |
| TBW02931 | 1420477-60-6 | Acalabrutinib |  |
C26H23N7O2 | >=98%(HPLC) |
| TBW02929 | 26543-89-5 | Cubebinolide |  |
C20H18O6 | >=98%(HPLC) |
| TBW02928 | 18423-69-3 | Cubebin |  |
C20H20O6 | >=98%(HPLC) |
| TBW02927 | 40456-50-6 | Dihydroanhydropodorhizol |  |
C22H24O7 | >=98%(HPLC) |
Contact Us
